• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Household transmission of SARS-CoV-2 in five US jurisdictions: Comparison of Delta and Omicron variants

tetano

Editor, Senior Moderator
PLoS One


. 2025 Jan 9;20(1):e0313680.
doi: 10.1371/journal.pone.0313680. eCollection 2025. Household transmission of SARS-CoV-2 in five US jurisdictions: Comparison of Delta and Omicron variants

Julia M Baker[SUP] 1 2 [/SUP], Jasmine Y Nakayama[SUP] 1 2 [/SUP], Michelle O'Hegarty[SUP] 1 [/SUP], Andrea McGowan[SUP] 1 3 [/SUP], Richard A Teran[SUP] 2 4 [/SUP], Stephen M Bart[SUP] 2 5 [/SUP], Lynn E Sosa[SUP] 5 [/SUP], Jessica Brockmeyer[SUP] 5 [/SUP], Kayla English[SUP] 4 [/SUP], Katie Mosack[SUP] 6 [/SUP], Sanjib Bhattacharyya[SUP] 6 [/SUP], Manjeet Khubbar[SUP] 6 [/SUP], Nicole R Yerkes[SUP] 7 [/SUP], Brooke Campos[SUP] 7 [/SUP], Alina Paegle[SUP] 7 [/SUP], John McGee[SUP] 7 [/SUP], Robert Herrera[SUP] 7 [/SUP], Marcia Pearlowitz[SUP] 8 [/SUP], Thelonious W Williams[SUP] 8 [/SUP], Hannah L Kirking[SUP] 1 [/SUP], Jacqueline E Tate[SUP] 1 [/SUP]



Affiliations
Abstract

Households are a significant source of SARS-CoV-2 transmission, even during periods of low community-level spread. Comparing household transmission rates by SARS-CoV-2 variant may provide relevant information about current risks and prevention strategies. This investigation aimed to estimate differences in household transmission risk comparing the SARS-CoV-2 Delta and Omicron variants using data from contact tracing and interviews conducted from November 2021 through February 2022 in five U.S. public health jurisdictions (City of Chicago, Illinois; State of Connecticut; City of Milwaukee, Wisconsin; State of Maryland; and State of Utah). Generalized estimating equations were used to estimate attack rates and relative risks for index case and household contact characteristics. Data from 848 households, including 2,622 individuals (median household size = 3), were analyzed. Overall transmission risk was similar in households with Omicron (attack rate = 47.0%) compared to Delta variant (attack rate = 48.0%) circulation. In the multivariable model, a pattern of increased transmission risk was observed with increased time since a household contact's last COVID-19 vaccine dose in Delta households, although confidence intervals overlapped (0-3 months relative risk = 0.8, confidence interval: 0.5-1.2; 4-7 months relative risk = 1.3, 0.9-1.8; ≥8 months relative risk = 1.2, 0.7-1.8); no pattern was observed in Omicron households. Risk for household contacts of symptomatic index cases was twice that of household contacts of asymptomatic index cases (relative risk = 2.0, 95% confidence interval: 1.4-2.9), emphasizing the importance of symptom status, regardless of variant. Uniquely, this study adjusted risk estimates for several index case and household contact characteristics and demonstrates that few characteristics strongly dictate risk, likely reflecting the complexity of the biological and social factors which combine to impact SARS-CoV-2 transmission.


 
Back
Top Bottom